Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Dry Powder Inhaler Market Grown from 2024 to 2025?

The market for dry powder inhalers has seen a significant increase in its size over the past years. The market is projected to expand from $21.25 billion in 2024 to $22.35 billion in 2025, with a compound annual growth rate (CAGR) of 5.2%. The historical growth of this market is a result of factors such as a rekindled interest in sustainable building materials, cultural preservation, restoration of heritage sites, an increase in eco-friendly building practices, local procurement and engagement of the community, and supportive regulations and building codes.

What Growth Rate Is Anticipated for the Dry Powder Inhaler Market in the Coming Years?

Expectations are high for consistent expansion in the dry powder inhaler market in the coming years. It is anticipated to escalate to a value of $27.13 billion by 2029, advancing at a compound annual growth rate (CAGR) of 5.0%. Factors contributing to growth during the prediction period include ongoing focus on sustainability, worldwide urbanization patterns, improvements in manufacturing methods, governmental support and economic influences on a global scale. The forecast period is set to witness an upsurge in research and development efforts, a revival of interest in age-old construction methodologies, progress in material technology, architectural and design progression, and regulatory backing for eco-friendly construction.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13430&type=smp

Who Are the Leading Companies in the Dry Powder Inhaler Market?

Major companies operating in the dry powder inhaler market report are Novartis AG, AstraZeneca plc., GlaxoSmithKline PLC, 3M Company, Boehringer Ingelheim GmbH, Viatris (Mylan N.V), Otsuka Pharmaceutical Co. Ltd., Sun Pharmaceutical Industries Limited, Catalent Inc., Aptar Group Inc., Chiesi Farmaceutici S.p.A., Recipharm AB, Cipla Limited, Lupin Limited, Orion Corporation, OPKO Health, Zhejiang Hisun Pharmaceutical Co Ltd., Beximco Pharmaceuticals Ltd., Sava Healthcare Ltd., Hovione, Elpen S.A., MannKind Corporation, Meda Pharmaceuticals, Presspart Manufacturing Ltd., SMB Laboratories SA, Teva Pharmaceutical Industries Limited, Pharmaxis Ltd., Iconovo AB, SRS Pharmaceuticals Pvt. Ltd.

What Are the Key Drivers of the Dry Powder Inhaler Market?

The accelerating incidence of respiratory ailments is anticipated to stimulate the expansion of the dry powder inhaler market. Respiratory diseases, referring to a vast category of lung disorders and other respiratory problems, are becoming more common. Dry powder inhalers, which dispense medication directly to the lungs where it’s most effective, are crucial for treating respiratory conditions like asthma, COPD and cystic fibrosis. These inhalers represent a beneficial replacement for traditional drug delivery methods associated with respiratory diseases. For example, a research study published by JAMA Network Open in December 2023, predicted that COPD cases worldwide could hit almost 600 million by 2050 – a 23% increase. It also suggested a 47.1% surge in female cases, with male cases expected to grow by 9.4%. Most notably these estimates indicated that the majority of cases would emerge in low and middle-income areas, where the prevalence will double compared to higher-income regions by 2050. As a result, the expanding incidence of respiratory diseases will boost the dry powder inhaler market.

Dry Powder Inhaler Market Driver: How Rising Air Pollution Levels Promote Growth in the Dry Powder Inhaler Market

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=13430&type=smp

What Are the Key Market Segments in the Dry Powder Inhaler Industry?

The dry powder inhaler market covered in this report is segmented –

1) By Product: Single-Dose Inhalers, Multi-Dose Inhalers

2) By Function: Manually Operated Inhaler Devices, Digitally Operated Inhaler Devices

3) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Other Applications

4) By End User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Single-Dose Inhalers: Capsule-Based Inhalers, Diskus-Based Inhalers

2) By Multi-Dose Inhalers: Blister-Based Inhalers, Rotahaler-Based Inhalers

What Are the Latest Trends in the Dry Powder Inhaler Market?

Key players in the dry powder inhaler market are advancing their product offerings by innovating muscarinic antagonist-based treatments for chronic obstructive pulmonary disease (COPD). Muscarinic antagonists are drugs that block the muscarinic acetylcholine receptor and are used to manage and treat a number of conditions, including COPD and organophosphate poisoning. Take for instance, Berry Global, a US company with a reputation for creating an array of flexible packaging solutions; they unveiled a new dry powder inhaler at Pharma pack in March 2024. This inhaler is engineered to optimize drug delivery for respiratory disorders such as COPD and asthma, providing a tailored solution to pharmaceutical companies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report

What Are the Key Regional Markets in the Dry Powder Inhaler Industry?

North America was the largest region in the dry powder inhaler market in 2024. The regions covered in the dry powder inhaler market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13430

This Report Delivers Insight On:

1. How big is the dry powder inhaler market, and how is it changing globally?

2. Who are the major companies in the dry powder inhaler market, and how are they performing?

3. What are the key opportunities and risks in the dry powder inhaler market right now?

4. Which products or customer segments are growing the most in the dry powder inhaler market?

5. What factors are helping or slowing down the growth of the dry powder inhaler market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model